Mary E. Temple, MS, PharmD, BCPS, FCCP

Mary E. Temple, MS, PharmD, BCPS, FCCP

Clinical Coordinator, Hillcrest Pharmacy Services
Hillcrest Hospital – a Cleveland Clinic Hospital
Phone: 440.312.2902
Fax: 440.312.8431
Email: mtemple@ccf.org
Cell: 216.385.7857

Clinical Specialist 2001-2017; Clinical Coordinator since 2018

Education

  • Master of Science, University of Florida, Gainesville, FL
  • ASHP Leadership Academy, Baltimore, MD
  • Doctor of Pharmacy, State University of New York at Buffalo, Buffalo, NY
  • Bachelor of Science in Pharmacy, The Ohio State University, Columbus, OH
  • Pediatric Pharmacotherapy Fellowship, Nationwide Children's and The Ohio State University, Columbus OH
  • Pharmacy Practice Residency, William Beaumont Hospital, Royal Oak, MI
  • Board Certified Pharmacotherapy Specialist

Past Experience Areas

  • Clinical Specialist, Pediatrics, Neonatal Medicine, Obstetrics
  • Retail Pharmacy
  • Nursing Home Consultant
  • Director of IRB
  • Staff Pharmacist
  • Teaching Assistant
  • Combat Medic

Areas of Interest

  • Health Care Policy
  • Pharmacy Administration
  • Opioid abuse in OB patients
  • Continuous Quality Improvement

Current Projects

  • Residency Program Director, PGY 1 Pharmacy Residency.
  • Clinical rounding with Cleveland Clinic, OB.
  • P&T, Pediatric QA Committee, OB QA Committee.
  • Consultant, Lexicomp Inc. pregnancy and lactation database.
  • Admission and discharge medication counseling program.
  • Continuous Quality Improvement with OB, Anesthesia and Pharmacy teams.
  • Student Education development for Cleveland Clinic.
  • Pharmacists Recognition and Advancement Program team for Cleveland Clinic.
  • Accreditation Team for Cleveland Clinic.
  • PRN Committee member, Women’s Health teaching and Education 2017-present.
  • Pediatric Consultant Pregnancy and Lactation Database, Lexicomp Inc. 2001-present.
  • Peer reviewer for AJHP 2001-present.
  • Resident/Student Women’s PRN committee member, ACCP 2012-2015.
  • Chairman, Public Policy, Women’s PRN ACCP 2013-2015.
  • Council of Health Care Advocates (COHCA) for Ohio, Board Member 2011-2017.
  • Health Policy Consultant for COCHA Political Advocacy Committee 2012-2017.
  • Membership currently in ASHP, ACCP, OPA, Cleveland Society of Health System Pharmacists.
  • Engagement team member, Pharmacy Department, Hillcrest Hospital.
  • Committee member for Anchored to Excellence, Service quality initiative.
  • Reviewer for Annals of Pharmacotherapy 2005-2008.
  • Cancer IRB member 2004-2006.
  • Director, CCHSEAST IRB 2003-2005.
  • Reviewer for Journal of Pediatric Pharmacology and Therapeutics 2000-2003.
  • Volunteer, Bainbridge food for Friends 2009-present.
  • Volunteer, Boy Scouts of America, 2005-2017.
  • Volunteer, Girl Scouts of America, 2009-present.
  • Apparel Chair, Kenston Parent Teacher Association, 2010-2014.
  • Veteran, United States Army: Iraq War.

Teaching

  • Instructor, Cleveland Clinic Technician School, 2015-present.
  • Visiting Instructor, Ohio College of Podiatry Medicine, 2001-2012.
  • Instruct Medical Residents monthly 2002-present.
  • Preceptor for Doctor of Pharmacy students 2002-present.
  • Provider of local continuing education for nurses, pharmacists and physicians at Hillcrest Hospital and in northeast Ohio.
  • Instructor, PA program Hillcrest Hospital.

Honors and Awards

  • Safety Champion, Hillcrest Hospital 2015.
  • Cleveland Clinic Health System Caregiver Award 2014.
  • Fellow, The American College of Clinical Pharmacy, 2014.
  • Summa Cum laude, Master of Science in Pharmacy, 2011.
  • Albert E. Dyckes Ohio Hospital Worker of the Year, Hillcrest Hospital, 2010.
  • The Chairman’s Award for Commitment to Clinical Research 2001, The Cleveland Clinic Foundation, Division of Pediatrics. This award is normally given to a physician.
  • Magna Cum Laude, Doctor of Pharmacy.

Publications

  • Temple ME, Nahata MC, Koranyi KI. Pharmacotherapy of tinea capitis. J Am Board Fam Pract 1999; 12:236-42.
  • Temple ME, Nahata MC. Interaction between ciprofloxacin and rifampin. Ann Pharmacother 1999; 33:868-70.
  • Wandstrat TL, Kaplan-Machlis B, Temple ME, Nahata MC. Tetravalent rotavirus vaccine. Ann Pharmacother 1999; 33:833-9.
  • Temple ME, Nahata MC. Rifapentine: Its role in the treatment of tuberculosis. Ann Pharmacother 1999; 33:1203-10.
  • Temple ME, Luzier A, Kazierad DJ. Homocysteine as a risk factor for atherosclerosis. Ann Pharmacother. 2000; 34:57-65.
  • Temple ME, Nahata MC. Pharmacotherapy of acute sinusitis in children. Am J Health Syst Pharm. 2000; 57:663-8.
  • Temple ME, Nahata MC. Comparative palatability of 22 liquid antacids. J Aliment Pharmacol Ther. 2000; 14:421-5.
  • Temple ME, Nahata MC. Treatment of listeriosis. Ann Pharmacother. 2000; 34:656-61.
  • Gilliland KK, Shermock KM, Flores P, Goldman MP, Temple-Cooper M, Calabrese AT, Schentag JJ. The A.U.I.C. (Antibiotic Utilization Information & Consultation) Program: utility in predicting clinical outcome. ICAAC 1999 Abstract 1006.
  • Temple ME, Nahata MC. Pharmacotherapy of lower limb diabetic ulcers. Journal of the American Geriatrics Society. 2000; 48:822-8.
  • Temple ME, Nahata MC. Treatment of pediatric hypertension. Pharmacotherapy. 2000; 20:140-50.
  • Temple ME, Koranyi KI, Nahata MC. Safety and antiviral effect of protease inhibitors in children. Pharmacotherapy. 2001; 21:287-94.
  • Temple ME, Koranyi KI, Nahata MC. Gastrostomy tube placement in non-adherent HIV infected children. Annals of Pharmacotherapy.
  • Temple ME, Brady M, Koranyi KI, Nahata MC. Periorbital cellulitis secondary to Conidiobolus incongruus. Pharmacotherapy. 2001; 21:351-54.
  • Shermock KM, Temple ME, Younossi ZM. The Cost-effectiveness of Treating Chronic Hepatitis C. Expert Opinion on Pharmacotherapy. 2002.
  • Shermock KM, Temple ME, Younossi ZM. A pharmacoeconomic appraisal of therapies for hepatitis B and C. Expert Opinion on Pharmacotherapy 2001; 2:205-211.
  • Temple ME, Koranyi KI, Nahata MC. Lipodystrophy in HIV- infected pediatric patients receiving protease inhibitors. Annals of Pharmacotherapy. 37(9):1214-8, 2003 Sept.
  • Temple ME, Miller JA, Nahata MC. Frequency, causality and preventability of adverse drug events in pediatric patients. Drug Safety. 27(11):819-29, 2004.
  • Temple ME, Arden SA, Bartos M, Paulin D, Jinks J. The effects of a bronchiolitis care path on clinical outcomes and length of stay in a pediatric community setting. Poster presented at ACCP 2004, manuscript in progress.
  • Temple ME, Jakubecz MA, Link NA. Implementation of a training program to improve pharmacy services for high risk neonatal and maternal populations. American Journal of Health System Pharmacists 2013; 70:144-149.
  • Rafie S, Borgelt L, Koepf ER, Temple-Cooper ME, Lehman KJ. Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest. International Journal of Women’s Health 2013; 5: 313–321.
  • Huebner M, Temple–Cooper ME, Lagzdins M, Yeh JY. A Pilot Study Evaluating the Effect Daily counseling by a Pharmacist on Medication Related HCAHPS Scores and Medication Reconciliation Satisfaction. J. Biosafety and Health education. 2013:1(2) http://dx.doi.org/10.4172/jbhe.1000105.
  • Temple-Cooper ME, Lagzdins M. Streamlining the residency interview process using available web-based technology. AJHP 2014:71;697-701.
  • Jakubecz MA, Phillipson E, Temple-Cooper ME. A Mother’s Stay in the Maternity Unit Yields an Opportunity to Vaccinate Fathers and Grandparents for Pertussis. AJHP 2016:74;e54-e58.
  • Link NA, Temple-Cooper ME. Correlation of AD use during Pregnancy and Autism: Unclear study design and inconsistencies in reported data. JAMA Pediatr 2016:170;441-442.
  • Hogue A , Temple-Cooper ME, Raich M , Schwersenski J, Floyd R, Saker F. Effects of In-Utero Exposure to Selective Serotonin Reuptake Inhibitors on Neonatal Outcomes. J Perinatol. 2017;10(4):1-10.
  • Vijayarajah S, Mary Temple-Cooper, Saker F. Baclofen withdrawal in a neonate. Pediatric Dimensions 2017;2:1-2.
  • Hoyt, M, Temple-Cooper ME An Observatioanl Case Series on the effect of clonidine epidural for pain control in patients who have received buprenprphine for opioid maintenance during pregnancy. Int J Obstet Anesth. 2018 May;34:67-72.

Poster Presentations

  • Kolenda M, Kuroski JE, Temple-Cooper ME. The Effect of a Therapeutic Guideline on Discharge Pain Prescriptions from an Emergency Department. Cleveland, OH 2018.
  • Kim S. Walker, Pharm.D.; Mary E. Temple-Cooper, Pharm.D., MS, BCPS, FCCP; Melissa Raich, Pharm.D., BCPS. Evaluation of Sepsis-3 Recommendations and Derivation of New Criteria to Predict the Risk of Mortality in Sepsis. Cleveland, OH May 2017.
  • Fink K, Temple ME. Oxytocin use in the obstetric population. The American Society of Health System Pharmacists. Las Vegas, Nevada Dec 2016.
  • Hansen K, Temple ME. Use of clonidine versus morphine for the treatment of neonatal abstinence syndrome. PAS; Baltimore, MD May 2016.
  • Temple ME. Implementation of a midyear oral examination to assess clinical competency and need for remediation in pharmacy residents. The American Society of Health System Pharmacists. Orlando, Florida December 2013.
  • Hogue A, Temple ME, et al. The effects in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on neonatal outcomes. Ohio College of Clinical Pharmacy, Cleveland, Ohio. 2013.
  • Temple ME, et al. Co-investigator. A pilot study evaluating the effects of daily counseling by a pharmacist on HCAHPS scores and medication reconciliation satisfaction. Ohio College of clinical Pharmacists. Cleveland, Ohio May 31, 2013.
  • Temple ME, et al. Co-investigator. Effects of in-utero exposure to SSRIs and venlafaxine on neonatal outcomes. Ohio College of clinical Pharmacists. Cleveland, Ohio May 31, 2013.
  • Temple ME, et al. Primary investigator. The effects of a bronchiolitis carepath on clinical outcomes and length of stay in a pediatric community setting, American College of Clinical Pharmacists, Dallas, Texas October 2004.
  • Temple ME, et al. Co-investigator. The value of Pharmacists in Preparation of Neonatal Care Protocols, Pediatric Pharmacy Advocacy Group, St. Petersburgh, Florida October 2004.
  • Temple ME, et al. Co-investigator. Neonates with single ventricle physiology have ultrasound evidence of poor mesenteric perfusion. Society of Critical Care Medicine, San Diego, California, January 26, 2002.
  • Temple ME, et al. Primary investigator. The Efficacy of Antimicrobial Stethoscope Covers in Reducing Bacterial Contamination of Stethoscopes. Pediatric Infectious Disease Society San Francisco, California, October 25, 2001.
  • Temple ME, et al. Primary Investigator. Lipodystrophy in HIV- infected pediatric patients receiving protease inhibitors. Boston Children’s Research Forum, Boston, Massachusetts, April 7, 2001.
  • Temple ME, et al. Primary investigator. A prospective study of the safety and efficacy of protease inhibitors in HIV infected children American College of Clinical Pharmacists Los Angeles, California, November 2000.
  • Temple ME, et al. Primary investigator. Gastrostomy tube placement in HIV-infected pediatric patients” Children’s Hospital Research Forum, Columbus, Ohio, June 2000.
  • Temple ME, et al. Primary investigator. A study of medication errors in an adult hospital”, American Society of Hospital Pharmacists, Miami Florida, December 1994.

Lecture Presentations

  • Neonatal Lecture Course: Series of 36 OB lectures combined with 36 NICU lectures. January 2018-present.
  • Common Drugs of Abuse and the implications for the inpatient practitioner. Hillcrest Hospital physician Assistant Grand Rounds. Mayfield Heights, Ohio. September 2017.
  • Maternal Medicine through the Years. Cleveland Clinic Pharmacy Technician School. Cleveland, Ohio July 2015, May 2016, March 2017.
  • Standardization of Epidural Anesthesia carts using SOLVD. Cleveland Clinic SOLVD Symposium Cleveland, OH June 2, 2016.
  • Antenatal Drug Abuse: Implications for the mother during labor, delivery and postpartum. Cleveland Clinical Obstetrics and Gynecology Physician Grand Rounds Mayfield Heights, Ohio July 2013.
  • Pearl and Challenges of Smart Pumps in the Neonatal Intensive Care Unit PPAG National Conference. Indianapolis, Indiana, May 1, 2013.
  • NICU Course, 65- one hour lectures in neonatology and obstetrics. Hillcrest Hospital Pharmacy Staff. Mayfield Heights, Ohio June 2009-November 2011, October 2012-2015.
  • Neonatal Opioid Withdrawal. PPAG National Conference, Cleveland, Ohio, October 20, 2009.
  • Pharmacology in the Neonate Neonatal Conference-level 3 preparation. Mayfield Heights, Ohio May 5, 2009.
  • Postpartum Hemmorhage. Neonatal Conference-level 3 preparation. Mayfield Heights, Ohio May 25, 2009.
  • TPN Basics. Neonatal Conference-level 3 preparation. Mayfield Heights, Ohio June 2, 2009.
  • In With the New, Out with the Old: How the 2007. Asthma Guidelines Affect Patient Management. Pennsylvania Society of Health System Pharmacists. Erie, PA, January 31, 2008.
  • The Use of SSRIs During Pregnancy and Lactation. Neonatal Consortium Meeting. Mayfield Heights, OH March 10, 2006.
  • Treatment Options for Pediatric Diabetes. Pediatric Pharmacy Advocacy Group Annual Meeting. Chicago, IL October 12, 2005.
  • Conscience Sedation: Options for Pre-surgical Procedures. Surgical Center, Hillcrest Hospital, Mayfield Heights, OH January 2005.
  • Pharmacotherapy Considerations in the Pediatric Patient. CCHS East Continuing Education Seminar. Huron Hospital, November 2004.
  • Immunizations in Children. Pediatric Physician/Nursing and Pharmacy CE Program Hillcrest Hospital, South Pointe Hospital, May 2003, January 2004.
  • Community Acquired Pneumonia in Children. Pediatric Physician/Nursing and Pharmacy CE Program. Hillcrest Hospital, May 2004.
  • Conscience Sedation: Options during Endoscopy and Colonoscopy. Pediatric Gastroenterology Department Hillcrest Hospital, February 2004.
  • Bronchiolitis and the Impact of a Care Path. Pediatric Physician/Nursing and Pharmacy CE Program. Hillcrest Hospital, November 2004.
  • Hyperlipidemia. Ohio College of Podiatry Medicine. Guest Speaker Cleveland, Ohio. April 2001-2011.
  • Pharmacotherapy of Patients with Diabetes Mellitus. Ohio College of Podiatry Medicine Guest Speaker Cleveland, Ohio. April 2001- 2009.
  • Frequency, Causality and preventability of adverse drug events in pediatric patients American College of Clinical Pharmacists Annual meeting Los Angeles, California.
  • Gastrostomy tube placement in HIV-infected pediatric patients. American College of Clinical Pharmacists Annual meeting. Los Angeles, California. November, 2000.
  • Periorbital cellulitis secondary to Conidiobolus incongruous. Children’s Hospital Research Forum. Columbus, Ohio, June 2000.
  • Acute Otitis Media in Children and Community acquired pneumonia. Doctor of Pharmacy Lecture Series. The Ohio State University, Columbus, Ohio. January 1999, 2000.
  • Accolate: A Milestone or Just Another Drug?” Doctor of Pharmacy Seminar. The State University of New York at Buffalo, October 1997.
  • Homocysteine: Another Pawn in the Atherosclerotic Battle. Doctor of Pharmacy Seminar. The State University of New York at Buffalo, March 1997.
  • Parenteral Nutrition in a Patient with Short Bowel Syndrome. Pharmacy Practice Conference. William Beaumont Hospital, June 1994.
  • Medication Omissions: A Study of Their Underlying Causes. Great Lakes Residency Conference. Toledo, OH. April 1994.
  • Pravastatin and a Review of HMG CoA Inhibitors. Pharmacy and Therapeutics Committee. William Beaumont Hospital, Royal Oak, MI. January 1994.